ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Clinical trial NCT05824559 · TERMINATED

Trial details

NCT number: NCT05824559
Sponsor: MEI Pharma, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2023-08-07
Primary completion: 2024-07-09
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.